Prothena (NASDAQ:PRTA) Price Target Cut to $31.00
Prothena (NASDAQ:PRTA – Get Free Report) had its price target decreased by equities research analysts at Bank of America from $33.00 to $31.00 in a research note issued on Tuesday, Benzinga reports. The brokerage presently has a “neutral” rating on the biotechnology company’s stock. Bank of America‘s price objective suggests a potential upside of 85.85% […]
More Stories
AC Immune (NASDAQ:ACIU) Rating Lowered to Hold at StockNews.com
StockNews.com downgraded shares of AC Immune (NASDAQ:ACIU – Free Report) from a buy rating to a hold rating in a...
Guardforce AI (NASDAQ:GFAI) Raised to Strong-Buy at EF Hutton Acquisition Co. I
EF Hutton Acquisition Co. I upgraded shares of Guardforce AI (NASDAQ:GFAI – Free Report) to a strong-buy rating in a...
Wizz Air (OTCMKTS:WZZZY) Upgraded to “Strong-Buy” by Sanford C. Bernstein
Sanford C. Bernstein upgraded shares of Wizz Air (OTCMKTS:WZZZY – Free Report) to a strong-buy rating in a research note...
StockNews.com Begins Coverage on Taitron Components (NASDAQ:TAIT)
StockNews.com began coverage on shares of Taitron Components (NASDAQ:TAIT – Free Report) in a report published on Tuesday. The brokerage...
Citigroup Upgrades Reckitt Benckiser Group (OTCMKTS:RBGLY) to “Strong-Buy”
Citigroup upgraded shares of Reckitt Benckiser Group (OTCMKTS:RBGLY – Free Report) to a strong-buy rating in a report released on...
GigCapital4, Inc.’s (OTCMKTS:GIGGU) Quiet Period To Expire on October 8th
GigCapital4’s (OTCMKTS:GIGGU – Get Free Report) quiet period will expire on Tuesday, October 8th. GigCapital4 had issued 20,000,000 shares in...